{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:22:50Z","timestamp":1788801770527,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-17324-3","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:48:09Z","timestamp":1759164489000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gender differences in opioid and stimulant poisoning in the central region of iran: a cross-sectional study"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9792-8160","authenticated-orcid":false,"given":"Nastaran","family":"Eizadi-Mood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnaz","family":"Barzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Pirali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awat","family":"Feizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9221-0608","authenticated-orcid":false,"given":"Melika","family":"Namvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elahe","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Mirmoghtadaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1070-8841","authenticated-orcid":false,"given":"Omid","family":"Mehrpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4536-5113","authenticated-orcid":false,"given":"Rokhsareh","family":"Meamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"issue":"1","key":"17324_CR1","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1186\/s12889-022-14506-w","volume":"22","author":"H Palis","year":"2022","unstructured":"Palis, H. et al. Concurrent use of opioids and stimulants and risk of fatal overdose: a cohort study. BMC Public. Health. 22 (1), 2084 (2022).","journal-title":"BMC Public. Health"},{"key":"17324_CR2","unstructured":"Opioid- and Stimulant-related Harms in Canada. [ (2024). Available from: https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids-stimulants\/"},{"issue":"1","key":"17324_CR3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/epirev\/mxaa011","volume":"42","author":"CM Jones","year":"2020","unstructured":"Jones, C. M., Bekheet, F., Park, J. N. & Alexander, G. C. The evolving overdose epidemic: synthetic opioids and rising stimulant-related harms. Epidemiol. Rev. 42 (1), 154\u2013166 (2020).","journal-title":"Epidemiol. Rev."},{"key":"17324_CR4","unstructured":"Holly Hedegaard, A. M. M. & Warner, M. Drug Overdose Deaths in the United States, 1999\u20132018 (National Center for Health Statistics, 2020). NCHS Data Brief, no 356."},{"issue":"9","key":"17324_CR5","doi-asserted-by":"publisher","first-page":"e2232314","DOI":"10.1001\/jamanetworkopen.2022.32314","volume":"5","author":"B Han","year":"2022","unstructured":"Han, B. et al. Racial and ethnic disparities in drug overdose deaths in the US during the COVID-19 pandemic. JAMA Netw. Open. 5 (9), e2232314\u2013e (2022).","journal-title":"JAMA Netw. Open."},{"issue":"1","key":"17324_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/1556-4029.15155","volume":"68","author":"L Glicksberg","year":"2023","unstructured":"Glicksberg, L., Dempsey, S. K. & Casey, B. K. Heroin and Fentanyl in Dallas county: A 5-year retrospective review of toxicological, seized drug, and demographical data. J. Forensic Sci. 68 (1), 222\u2013232 (2023).","journal-title":"J. Forensic Sci."},{"key":"17324_CR7","doi-asserted-by":"publisher","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","volume":"69","author":"N Wilson","year":"2020","unstructured":"Wilson, N. Drug and opioid-involved overdose deaths\u2014United states, 2017\u20132018. MMWR Morbidity Mortal. Wkly. Rep. 69, 290\u2013297 (2020).","journal-title":"MMWR Morbidity Mortal. Wkly. Rep."},{"issue":"5","key":"17324_CR8","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/add.16105","volume":"118","author":"N Krawczyk","year":"2023","unstructured":"Krawczyk, N. et al. COVID-19 complications among patients with opioid use disorder: a retrospective cohort study across five major NYC hospital systems. Addiction 118 (5), 857\u2013869 (2023).","journal-title":"Addiction"},{"issue":"4","key":"17324_CR9","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","volume":"34","author":"D Ciccarone","year":"2021","unstructured":"Ciccarone, D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr. Opin. Psychiatry. 34 (4), 344\u2013350 (2021).","journal-title":"Curr. Opin. Psychiatry"},{"issue":"4","key":"17324_CR10","first-page":"327","volume":"42","author":"S Alinejad","year":"2017","unstructured":"Alinejad, S., Zamani, N., Abdollahi, M. & Mehrpour, O. A narrative review of acute adult poisoning in Iran. Iran. J. Med. Sci. 42 (4), 327 (2017).","journal-title":"Iran. J. Med. Sci."},{"key":"17324_CR11","doi-asserted-by":"publisher","first-page":"103529","DOI":"10.1016\/j.drugpo.2021.103529","volume":"100","author":"Y Rostam-Abadi","year":"2022","unstructured":"Rostam-Abadi, Y. et al. Public health risks associated with methadone in iran: A systematic review and meta-analysis. Int. J. Drug Policy. 100, 103529 (2022).","journal-title":"Int. J. Drug Policy"},{"issue":"4","key":"17324_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1177\/0960327108099679","volume":"28","author":"M Islambulchilar","year":"2009","unstructured":"Islambulchilar, M., Islambulchilar, Z. & Kargar-Maher, M. Acute adult poisoning cases admitted to a university hospital in Tabriz. Iran. Hum. Experimental Toxicol. 28 (4), 185\u2013190 (2009).","journal-title":"Iran. Hum. Experimental Toxicol."},{"issue":"1","key":"17324_CR13","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1038\/s41598-023-28353-1","volume":"13","author":"K Naseri","year":"2023","unstructured":"Naseri, K. et al. Pharmaceutical toxicity is a common pattern of inpatient acute poisonings in Birjand city, East of Iran. Sci. Rep. 13 (1), 1312 (2023).","journal-title":"Sci. Rep."},{"issue":"1","key":"17324_CR14","doi-asserted-by":"publisher","first-page":"10493","DOI":"10.1038\/s41598-024-61411-w","volume":"14","author":"N Eizadi-Mood","year":"2024","unstructured":"Eizadi-Mood, N. et al. Clinico-epidemiological evaluation of pharmaceutical\/non-pharmaceutical poisoning in a referral poisoning emergency in the central part of Iran. Sci. Rep. 14 (1), 10493 (2024).","journal-title":"Sci. Rep."},{"key":"17324_CR15","unstructured":"Hunter, M. & MacBeath, A. The Impact of Afghanistan\u2019s Drug Trade on its Neighbours. (2023)."},{"issue":"8","key":"17324_CR16","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.1097\/PCC.0000000000000506","volume":"16","author":"H Hassanian-Moghaddam","year":"2015","unstructured":"Hassanian-Moghaddam, H. et al. Stimulant toxicity in children: a retrospective study on 147 patients. Pediatr. Crit. Care Med. 16 (8), e290\u2013e6 (2015).","journal-title":"Pediatr. Crit. Care Med."},{"issue":"1","key":"17324_CR17","first-page":"e1","volume":"6","author":"M Rahimi","year":"2018","unstructured":"Rahimi, M. et al. Predictive factors of mortality in acute amphetamine type stimulants poisoning; a review of 226 cases. Emergency 6 (1), e1 (2018).","journal-title":"Emergency"},{"issue":"3","key":"17324_CR18","first-page":"245","volume":"23","author":"B Shadloo","year":"1995","unstructured":"Shadloo, B. et al. Use of amphetamine-type stimulants in the Islamic Republic of iran, 2004\u20132015: a review. EMHJ 23 (3), 245\u2013256 (1995).","journal-title":"EMHJ"},{"issue":"1","key":"17324_CR19","first-page":"11","volume":"5","author":"T Ghane","year":"2016","unstructured":"Ghane, T. et al. Toxic agents responsible for acute poisonings treated at four medical settings in Iran during 2012\u20132013: A report from iran\u2019s National drug and poison information center. Asia Pac. J. Med. Toxicol. 5 (1), 11\u201314 (2016).","journal-title":"Asia Pac. J. Med. Toxicol."},{"key":"17324_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.drugpo.2019.09.018","volume":"73","author":"G Moradi","year":"2019","unstructured":"Moradi, G. et al. Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran. Int. J. Drug Policy. 73, 129\u2013134 (2019).","journal-title":"Int. J. Drug Policy"},{"issue":"6","key":"17324_CR21","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/14659891.2021.1879289","volume":"26","author":"L Abedi Gheshlaghi","year":"2021","unstructured":"Abedi Gheshlaghi, L. et al. Prevalence of amphetamine-type stimulants use in iran: a systematic review and meta-analysis. J. Subst. Use. 26 (6), 569\u2013585 (2021).","journal-title":"J. Subst. Use"},{"issue":"10","key":"17324_CR22","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1111\/add.13453","volume":"111","author":"M Amin-Esmaeili","year":"2016","unstructured":"Amin-Esmaeili, M. et al. Epidemiology of illicit drug use disorders in iran: prevalence, correlates, comorbidity and service utilization results from the Iranian mental health survey. Addiction 111 (10), 1836\u20131847 (2016).","journal-title":"Addiction"},{"key":"17324_CR23","unstructured":"World Drug Report. (United Nations publication, Sales No. E.19.XI.8) [ (2019). Available from: https:\/\/wdr.unodc.org\/wdr2019\/prelaunch\/WDR19_Booklet_4_STIMULANTS.pdf"},{"issue":"2","key":"17324_CR24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s12024-020-00339-9","volume":"17","author":"S Paknahad","year":"2021","unstructured":"Paknahad, S., Akhgari, M. & Ghadipasha, M. An alarming rise in the prevalence of deaths with methamphetamine involved in tehran, Iran 2011\u20132018. Forensic Sci. Med. Pathol. 17 (2), 208\u2013215 (2021).","journal-title":"Forensic Sci. Med. Pathol."},{"issue":"1","key":"17324_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40360-024-00759-1","volume":"25","author":"B Mesgarpour","year":"2024","unstructured":"Mesgarpour, B. et al. Age-and gender-specific acute poisoning with drugs and medications affecting nervous system. BMC Pharmacol. Toxicol. 25 (1), 37 (2024).","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"3","key":"17324_CR26","first-page":"80","volume":"3","author":"F Khodabandeh","year":"2013","unstructured":"Khodabandeh, F. Gender difference in the characteristics among unintentional methamphetamine overdose patients referring to poison center-an epidemiologic survey. Inter J. Med. Toxicol. Forensic Med. 3 (3), 80\u201387 (2013).","journal-title":"Inter J. Med. Toxicol. Forensic Med."},{"issue":"676","key":"17324_CR27","first-page":"435","volume":"40","author":"G Dorooshi","year":"2022","unstructured":"Dorooshi, G. et al. Risk factors for opioids and stimulants poisoning among patients admitted to Khorshid hospital in Isfahan. J. Isfahan Med. School. 40 (676), 435\u2013442 (2022).","journal-title":"J. Isfahan Med. School"},{"issue":"6","key":"17324_CR28","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/ADM.0000000000000245","volume":"10","author":"TW Park","year":"2016","unstructured":"Park, T. W. et al. Understanding risk factors for opioid overdose in clinical populations to inform treatment and policy. J. Addict. Med. 10 (6), 369\u2013381 (2016).","journal-title":"J. Addict. Med."},{"key":"17324_CR29","doi-asserted-by":"publisher","first-page":"105946","DOI":"10.1016\/j.ypmed.2019.105946","volume":"131","author":"ER Silver","year":"2020","unstructured":"Silver, E. R. & Hur, C. Gender differences in prescription opioid use and misuse: implications for men\u2019s health and the opioid epidemic. Prev. Med. 131, 105946 (2020).","journal-title":"Prev. Med."},{"key":"17324_CR30","doi-asserted-by":"crossref","unstructured":"Spencer, M. R. et al. Estimates of drug overdose deaths involving fentanyl, methamphetamine, cocaine, heroin, and oxycodone: United States, 2023. (2021).","DOI":"10.15620\/cdc:125504"},{"key":"17324_CR31","doi-asserted-by":"crossref","unstructured":"VanHouten, J. P. Drug overdose deaths among women aged 30\u201364 years\u2014United states, 1999\u20132017. MMWR Morbidity and mortality weekly report. ;68:, 1\u20135 (2019).","DOI":"10.15585\/mmwr.mm6801a1"},{"issue":"1","key":"17324_CR32","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/ADM.0000000000000086","volume":"9","author":"J Manubay","year":"2015","unstructured":"Manubay, J. et al. Sex differences among opioid-abusing patients with chronic pain in a clinical trial. J. Addict. Med. 9 (1), 46\u201352 (2015).","journal-title":"J. Addict. Med."},{"key":"17324_CR33","doi-asserted-by":"publisher","first-page":"109946","DOI":"10.1016\/j.drugalcdep.2023.109946","volume":"249","author":"A Jones","year":"2023","unstructured":"Jones, A. et al. Opioid and stimulant attributed treatment admissions and fatal overdoses: using National surveillance data to examine the intersection of race, sex, and polysubstance use, 1992\u20132020. Drug Alcohol Depend. 249, 109946 (2023).","journal-title":"Drug Alcohol Depend."},{"key":"17324_CR34","first-page":"1","volume":"17","author":"H Ramezanzadeh","year":"2024","unstructured":"Ramezanzadeh, H. et al. Epidemiological aspects of opioid poisoning in Northern iran: a registry-based clinical study. Health Serv. Insights. 17, 1\u20135 (2024).","journal-title":"Health Serv. Insights"},{"key":"17324_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.sste.2018.01.001","volume":"25","author":"M Rostami","year":"2018","unstructured":"Rostami, M., Karamouzian, M., Khosravi, A. & Rezaeian, S. Gender and geographical inequalities in fatal drug overdose in iran: A province-level study in 2006 and 2011. Spat. spatio-temporal Epidemiol. 25, 19\u201324 (2018).","journal-title":"Spat. spatio-temporal Epidemiol."},{"key":"17324_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.sste.2017.05.002","volume":"22","author":"M Rostami","year":"2017","unstructured":"Rostami, M., Mohammadi, Y., Jalilian, A. & Nazparvar, B. Modeling spatio-temporal variations of substance abuse mortality in Iran using a log-Gaussian Cox point process. Spat. spatio-temporal Epidemiol. 22, 15\u201325 (2017).","journal-title":"Spat. spatio-temporal Epidemiol."},{"issue":"5","key":"17324_CR37","first-page":"0","volume":"17","author":"M Naghavi","year":"2014","unstructured":"Naghavi, M. et al. Health transition in Iran toward chronic diseases based on results of global burden of disease 2010. Arch. Iran. Med. 17 (5), 0 (2014).","journal-title":"Arch. Iran. Med."},{"key":"17324_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1478-7954-5-7","volume":"5","author":"A Khosravi","year":"2007","unstructured":"Khosravi, A., Taylor, R., Naghavi, M. & Lopez, A. D. Differential mortality in Iran. Popul. Health Metrics. 5, 1\u201315 (2007).","journal-title":"Popul. Health Metrics"},{"issue":"1","key":"17324_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1360-0443.2011.03601.x","volume":"107","author":"JD Livingston","year":"2012","unstructured":"Livingston, J. D., Milne, T., Fang, M. L. & Amari, E. The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review. Addiction 107 (1), 39\u201350 (2012).","journal-title":"Addiction"},{"issue":"8","key":"17324_CR40","first-page":"1592","volume":"49","author":"MRS Rezaeian","year":"2019","unstructured":"Rezaeian, M. R. S. Challenges of estimates in Drug-Related overdose deaths in iran: evidence from the literature. Iran. J. Public. Health. 49 (8), 1592\u20131593 (2019).","journal-title":"Iran. J. Public. Health"},{"issue":"4","key":"17324_CR41","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.toxac.2023.06.002","volume":"35","author":"F Baberi","year":"2023","unstructured":"Baberi, F., Mirtorabi, D., Mahdavi, S. A., Hamedi, A. & Nazari, S. S. H. Spatial analysis of drug abuse mortality rates in Iran. Toxicol. Anal. Et Clinique. 35 (4), 342\u2013349 (2023).","journal-title":"Toxicol. Anal. Et Clinique"},{"issue":"4","key":"17324_CR42","first-page":"395","volume":"17","author":"SMS Ghoreishi","year":"2017","unstructured":"Ghoreishi, S. M. S., Shahbazi, F., Mirtorabi, S. D., Ghadirzadeh, M. R. & Nazari, S. S. H. Epidemiological study of mortality rate from alcohol and illicit drug abuse in Iran. J. Res. Health Sci. 17 (4), 395 (2017).","journal-title":"J. Res. Health Sci."},{"issue":"2","key":"17324_CR43","doi-asserted-by":"publisher","first-page":"32400","DOI":"10.32598\/ijmtfm.v11i2.32400","volume":"11","author":"F Baberi","year":"2021","unstructured":"Baberi, F. et al. Assessing substances Abuse-In-duced mortality rates by autopsy method in Iran. Int. J. Med. Toxicol. Forensic Med. 11 (2), 32400 (2021).","journal-title":"Int. J. Med. Toxicol. Forensic Med."},{"key":"17324_CR44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cpr.2017.10.012","volume":"66","author":"RK McHugh","year":"2018","unstructured":"McHugh, R. K., Votaw, V. R., Sugarman, D. E. & Greenfield, S. F. Sex and gender differences in substance use disorders. Clin. Psychol. Rev. 66, 12\u201323 (2018).","journal-title":"Clin. Psychol. Rev."},{"key":"17324_CR45","unstructured":"Quality, C. B. H. S. National Survey on Drug Use and Health: Detailed Tables.Substance Abuse and Mental Health Services Administration. Rockville, MD. 2017. (2016)."},{"issue":"3","key":"17324_CR46","doi-asserted-by":"publisher","first-page":"e587","DOI":"10.1002\/hsr2.587","volume":"5","author":"A Banaye Yazdipour","year":"2022","unstructured":"Banaye Yazdipour, A. et al. The trend of top five types of poisonings in hospitalized patients based on ICD-10 in the Northeast of Iran during 2012\u20132018: A cross\u2010sectional study. Health Sci. Rep. 5 (3), e587 (2022).","journal-title":"Health Sci. Rep."},{"issue":"4","key":"17324_CR47","first-page":"202","volume":"9","author":"N Eizadi-Mood","year":"2020","unstructured":"Eizadi-Mood, N., Haghshenas, E., Sabzghabaee, A. M., Yaraghi, A. & Farajzadegan, Z. Common opioids involved in drug poisoning presenting to the emergency department: A cross-sectional study. J. Res. Pharm. Pract. 9 (4), 202\u2013207 (2020).","journal-title":"J. Res. Pharm. Pract."},{"issue":"11","key":"17324_CR48","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/s41386-023-01601-8","volume":"48","author":"ER Butelman","year":"2023","unstructured":"Butelman, E. R. et al. Overdose mortality rates for opioids and stimulant drugs are substantially higher in men than in women: state-level analysis. Neuropsychopharmacology 48 (11), 1639\u20131647 (2023).","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"17324_CR49","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/j.socscimed.2007.02.035","volume":"64","author":"JR Mahalik","year":"2007","unstructured":"Mahalik, J. R., Burns, S. M. & Syzdek, M. Masculinity and perceived normative health behaviors as predictors of men\u2019s health behaviors. Soc. Sci. Med. 64 (11), 2201\u20132209 (2007).","journal-title":"Soc. Sci. Med."},{"issue":"1","key":"17324_CR50","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1037\/men0000199","volume":"21","author":"DS Berke","year":"2020","unstructured":"Berke, D. S., Leone, R., Parrott, D. & Gallagher, K. E. Drink, don\u2019t think: the role of masculinity and thought suppression in men\u2019s alcohol-related aggression. Psychol. Men Masculinities. 21 (1), 36 (2020).","journal-title":"Psychol. Men Masculinities"},{"issue":"9","key":"17324_CR51","doi-asserted-by":"publisher","first-page":"5354","DOI":"10.19082\/5354","volume":"9","author":"A Ghaderi","year":"2017","unstructured":"Ghaderi, A., Motmaen, M., Abdi, I. & Rasouli-Azad, M. Gender differences in substance use patterns and disorders among an Iranian patient sample receiving methadone maintenance treatment. Electron. Physician. 9 (9), 5354 (2017).","journal-title":"Electron. Physician"},{"issue":"3","key":"17324_CR52","first-page":"1","volume":"68","author":"MR Spencer","year":"2019","unstructured":"Spencer, M. R., Warner, M., Bastian, B. A., Trinidad, J. P. & Hedegaard, H. Drug overdose deaths involving fentanyl, 2011\u20132016. National vital statistics reports: from the centers for disease control and prevention, National center for health statistics. Natl. Vital Stat. Syst. 68 (3), 1\u201319 (2019).","journal-title":"Natl. Vital Stat. Syst."},{"issue":"2","key":"17324_CR53","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1177\/0033354920968806","volume":"136","author":"RA Hoopsick","year":"2021","unstructured":"Hoopsick, R. A., Homish, G. G. & Leonard, K. E. Differences in opioid overdose mortality rates among middle-aged adults by race\/ethnicity and sex, 1999\u20132018. Public Health Rep. 136 (2), 192\u2013200 (2021).","journal-title":"Public Health Rep."},{"issue":"8","key":"17324_CR54","doi-asserted-by":"publisher","first-page":"e0134550","DOI":"10.1371\/journal.pone.0134550","volume":"10","author":"E Kaplovitch","year":"2015","unstructured":"Kaplovitch, E. et al. Sex differences in dose escalation and overdose death during chronic opioid therapy: a population-based cohort study. PloS One. 10 (8), e0134550 (2015).","journal-title":"PloS One"},{"issue":"1","key":"17324_CR55","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jsat.2012.12.007","volume":"45","author":"RK McHugh","year":"2013","unstructured":"McHugh, R. K. et al. Gender differences in a clinical trial for prescription opioid dependence. J. Subst. Abuse Treat. 45 (1), 38\u201343 (2013).","journal-title":"J. Subst. Abuse Treat."},{"issue":"4","key":"17324_CR56","first-page":"111","volume":"5","author":"E Farzaneh","year":"2016","unstructured":"Farzaneh, E., Amani, F. & Etemad, F. A clinico-epidemiologic study on patients with opium toxicity treated at ardabil hospitals, iran, 2014\u20132015. Asia Pac. J. Med. Toxicol. 5 (4), 111\u2013114 (2016).","journal-title":"Asia Pac. J. Med. Toxicol."},{"issue":"10","key":"17324_CR57","doi-asserted-by":"publisher","first-page":"564","DOI":"10.5694\/j.1326-5377.2007.tb01417.x","volume":"187","author":"PJ Bunting","year":"2007","unstructured":"Bunting, P. J., Fulde, G. W. & Forster, S. L. Comparison of crystalline methamphetamine (ice) users and other patients with toxicology-related problems presenting to a hospital emergency department. Med. J. Aust. 187 (10), 564\u2013566 (2007).","journal-title":"Med. J. Aust."},{"issue":"12","key":"17324_CR58","doi-asserted-by":"publisher","first-page":"e2030201","DOI":"10.1001\/jamanetworkopen.2020.30201","volume":"3","author":"SM Bagley","year":"2020","unstructured":"Bagley, S. M. et al. Incidence and characteristics of nonfatal opioid overdose among youths aged 11 to 24 years by sex. JAMA Netw. Open. 3 (12), e2030201\u2013e (2020).","journal-title":"JAMA Netw. Open."},{"issue":"9","key":"17324_CR59","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3109\/15563650.2012.731510","volume":"50","author":"M Glaizal","year":"2012","unstructured":"Glaizal, M. et al. Suicidal poisonings with methadone in france: results of a two year National survey by the toxicovigilance network. Clin. Toxicol. 50 (9), 841\u2013846 (2012).","journal-title":"Clin. Toxicol."},{"issue":"2","key":"17324_CR60","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/PAF.0b013e3181e8af3d","volume":"32","author":"ME Madden","year":"2011","unstructured":"Madden, M. E. & Shapiro, S. L. The methadone epidemic: methadone-related deaths on the rise in Vermont. Am. J. Forensic. Med. Pathol. 32 (2), 131\u2013135 (2011).","journal-title":"Am. J. Forensic. Med. Pathol."},{"issue":"3","key":"17324_CR61","first-page":"104","volume":"3","author":"K Soltaninejad","year":"2014","unstructured":"Soltaninejad, K., Hassanian-Moghaddam, H. & Shadnia, S. Methadone related poisoning on the rise in tehran, Iran. Asia Pac. J. Med. Toxicol. 3 (3), 104\u2013109 (2014).","journal-title":"Asia Pac. J. Med. Toxicol."},{"issue":"8","key":"17324_CR62","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3109\/15563650.2013.830732","volume":"51","author":"S Shadnia","year":"2013","unstructured":"Shadnia, S., Rahimi, M., Hassanian-Moghaddam, H., Soltaninejad, K. & Noroozi, A. Methadone toxicity: comparing tablet and syrup formulations during a decade in an academic poison center of Iran. Clin. Toxicol. 51 (8), 777\u2013782 (2013).","journal-title":"Clin. Toxicol."},{"issue":"3","key":"17324_CR63","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4103\/2279-042X.122387","volume":"2","author":"F Taheri","year":"2013","unstructured":"Taheri, F. et al. Methadone toxicity in a poisoning referral center. J. Res. Pharm. Pract. 2 (3), 130\u2013134 (2013).","journal-title":"J. Res. Pharm. Pract."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17324-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17324-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17324-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T02:05:11Z","timestamp":1759543511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17324-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["17324"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-17324-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33506"}}